These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25229333)

  • 1. Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia.
    Raz S; Stark M; Assaraf YG
    Oncotarget; 2014 Oct; 5(19):9183-98. PubMed ID: 25229333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
    Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
    Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia.
    Stark M; Wichman C; Avivi I; Assaraf YG
    Blood; 2009 Apr; 113(18):4362-9. PubMed ID: 19131550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.
    Raz S; Stark M; Assaraf YG
    Drug Resist Updat; 2016 Sep; 28():43-64. PubMed ID: 27620954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folylpoly-gamma-glutamate synthetase: generation of isozymes and the role in one carbon metabolism and antifolate cytotoxicity.
    Qi H; Atkinson I; Xiao S; Choi YJ; Tobimatsu T; Shane B
    Adv Enzyme Regul; 1999; 39():263-73. PubMed ID: 10470377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of folylpoly-gamma-glutamate synthetase gene expression in human B-precursor ALL and T-lineage ALL cells.
    Leclerc GJ; Leclerc GM; Kinser TT; Barredo JC
    BMC Cancer; 2006 May; 6():132. PubMed ID: 16707018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance.
    Wojtuszkiewicz A; Raz S; Stark M; Assaraf YG; Jansen G; Peters GJ; Sonneveld E; Kaspers GJ; Cloos J
    Int J Cancer; 2016 Apr; 138(7):1645-56. PubMed ID: 26547381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
    McGuire JJ; Russell CA
    Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different antifolate-resistant L1210 cell variants with either increased or decreased folylpolyglutamate synthetase gene expression at the level of mRNA transcription.
    Roy K; Mitsugi K; Sirlin S; Shane B; Sirotnak FM
    J Biol Chem; 1995 Nov; 270(45):26918-22. PubMed ID: 7592937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
    Leclerc GJ; Mou C; Leclerc GM; Mian AM; Barredo JC
    Leukemia; 2010 Mar; 24(3):552-62. PubMed ID: 20072153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription of the human folylpoly-gamma-glutamate synthetase gene.
    Freemantle SJ; Moran RG
    J Biol Chem; 1997 Oct; 272(40):25373-9. PubMed ID: 9312158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation Screening and Association Study of the Folylpolyglutamate Synthetase (FPGS) Gene with Susceptibility to Childhood Acute Lymphoblastic Leukemia.
    Piwkham D; Siriboonpiputtana T; Beuten J; Pakakasama S; Gelfond JA; Paisooksantivatana K; Tomlinson GE; Rerkamnuaychoke B
    Asian Pac J Cancer Prev; 2015; 16(11):4727-32. PubMed ID: 26107232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable expression of the folylpolyglutamate synthetase gene at the level of mRNA transcription in human leukemia cell lines sensitive, or made resistant, to various antifolate drugs.
    Takemura Y; Kobayashi H; Miyachi H
    Anticancer Drugs; 1999 Aug; 10(7):677-83. PubMed ID: 10507318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo.
    Aghi M; Kramm CM; Breakefield XO
    J Natl Cancer Inst; 1999 Jul; 91(14):1233-41. PubMed ID: 10413425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients.
    Lenz HJ; Danenberg K; Schnieders B; Goeker E; Peters GJ; Garrow T; Shane B; Bertino JR; Danenberg PV
    Oncol Res; 1994; 6(7):329-35. PubMed ID: 7865908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanizing mouse folate metabolism: conversion of the dual-promoter mouse folylpolyglutamate synthetase gene to the human single-promoter structure.
    Yang C; Xie LY; Windle JJ; Taylor SM; Moran RG
    FASEB J; 2014 May; 28(5):1998-2008. PubMed ID: 24532667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of the reduced folate carrier and folypolyglutamate synthetase is the basis for acquired resistance to the pemetrexed antifolate (LY231514) in an L1210 murine leukemia cell line.
    Wang Y; Zhao R; Goldman ID
    Biochem Pharmacol; 2003 Apr; 65(7):1163-70. PubMed ID: 12663051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance studies of folylpolyglutamate synthetase-deficient, methotrexate-resistant CCRF-CEM human leukemia sublines.
    McGuire JJ; Heitzman KJ; Haile WH; Russell CA; McCloskey DE; Piper JR
    Leukemia; 1993 Dec; 7(12):1996-2003. PubMed ID: 8255099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folylpolyglutamate synthetase inactivation in relapsed ALL induces a druggable folate metabolic vulnerability.
    Li H; Chen Y; Ding M; Liu J; Sun H; Fang H; Brady SW; Xu Y; Glaser F; Ma X; Tang Y; Du L; Wu X; Wang S; Zhu L; Li B; Shen S; Zhang J; Zheng L; Yu J; Assaraf YG; Zhou BS
    Drug Resist Updat; 2024 Nov; 77():101141. PubMed ID: 39181011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.